Differential expression of VEGFR1, VEGFR2 and VEGFR3 is observed in various stages of cervical, prostate and ovarian cancer, with VEGFR3 often being overexpressed in advanced stages [58]. Here, FLT4 is linked to ovarian carcinoma.